Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > IMRX Immuneering > Company Executives
IMRX Immuneering
5.600
-0.070-1.23%
NamePositionSalaryService DateEducationAgeGenderUpdated
Dr. Benjamin J. Zeskind, PhDPresident, Chief Executive Officer and Director2.54M----40male05/02/2022
Dr. Scott Barrett, M.D.Chief Medical Officer715.40K----59male05/02/2022
Dr. Brett Hall, PhDChief Scientific Officer2.52M----53male05/02/2022
Ms. Mallory MoralesPrincipal Financial Officer, Principal Accounting Officer and Treasurer------39female07/25/2022
Mr. Michael D. BookmanGeneral Counsel and Secretary------35male05/02/2022
Mr. Robert J. CarpenterChairman of the Board and Lead Independent Director36.01K----77male05/02/2022
Mr. Peter FeinbergDirector14.74K----61male05/02/2022
Ms. Ann E. BermanIndependent Director366.96K----69female05/02/2022
Ms. Laurie B. Keating, J.D.Independent Director224.21K----68female05/02/2022
Company Overview More
Immuneering Corp. engages in the development of new medicines which are unlikely to be found by traditional drug discovery methods. Its pipeline of drug candidates focuses on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis. The company was founded by Robert J. Carpenter and Benjamin J. Zeskind in 2008 and is headquartered in Cambridge, MA.
CEO: Dr. Benjamin J. Zeskind, PhD
Market: NASDAQ
Listing Date: 07/30/2021
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist